Retraction Note to: Oncogene https://doi.org/10.1038/sj.onc.1207247, published online 19 February 2004
The Editors in Chief have retracted this article following a review by Harvard Medical School and the Brigham and Women’s Hospital that identified discrepancies in figure 1. There was no underlying research data available to resolve these discrepancies or to validate the reported results. Hiromichi Ito, Michael J Zinner, and Stanley W Ashley agree to this retraction. Mark S Duxbury and Edward E Whang do not agree with this retraction.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Duxbury, M.S., Ito, H., Zinner, M.J. et al. Retraction Note: EphA2: a determinant of malignant cellular behavior and a potential therapeutic target in pancreatic adenocarcinoma. Oncogene 42, 938 (2023). https://doi.org/10.1038/s41388-023-02626-5
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41388-023-02626-5
